新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300765 新诺威

已收盘 07-22 15:00:00

{"stockData":{"symbol":"300765","market":"SZ","secType":"STK","nameCN":"新诺威","latestPrice":52.53,"timestamp":1753167798000,"preClose":54.73,"halted":0,"volume":8231834,"delay":0,"changeRate":-0.0402,"floatShares":1247000000,"shares":1405000000,"eps":-0.0372,"marketStatus":"已收盘","change":-2.2,"latestTime":"07-22 15:00:00","open":54,"high":55.15,"low":52.28,"amount":441000000,"amplitude":0.0524,"askPrice":52.54,"askSize":15,"bidPrice":52.53,"bidSize":51,"shortable":0,"etf":0,"ttmEps":-0.0372,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753234200000},"marketStatusCode":5,"adr":0,"adjPreClose":54.73,"symbolType":"stock","openAndCloseTimeList":[[1753147800000,1753155000000],[1753160400000,1753167600000]],"highLimit":60.2,"lowLimit":49.26,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1404592944,"isCdr":false,"pbRate":20.74,"roa":"--","roe":"--","epsLYR":0.0384,"committee":0.378685,"marketValue":73783000000,"turnoverRate":0.0066,"status":1,"floatMarketCap":65509000000},"requestUrl":"/m/hq/s/300765","defaultTab":"news","newsList":[{"id":"2551152373","title":"7月15日新诺威涨5.81%，工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551152373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551152373?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:19","pubTimestamp":1752567566,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日新诺威涨5.81%，收盘报54.31元，换手率1.14%，成交量14.21万手，成交额7.62亿元。重仓新诺威的前十大公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共61家，其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071500026728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","159891","300765"],"gpt_icon":0},{"id":"2551770901","title":"新诺威：SYS6040临床试验目前正常开展中","url":"https://stock-news.laohu8.com/highlight/detail?id=2551770901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551770901?lang=zh_cn&edition=full","pubTime":"2025-07-14 17:33","pubTimestamp":1752485592,"startTime":"0","endTime":"0","summary":"证券之星消息，新诺威(300765)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：SYS6040实验进展如何新诺威回复：您好，感谢您对公司的关注，SYS6040临床试验目前正常开展中，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400025395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","03347","BK0226","300765","BK1141","BK1576"],"gpt_icon":0},{"id":"2551185922","title":"新诺威净利润创新低，76亿并购告吹","url":"https://stock-news.laohu8.com/highlight/detail?id=2551185922","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551185922?lang=zh_cn&edition=full","pubTime":"2025-07-14 09:29","pubTimestamp":1752456540,"startTime":"0","endTime":"0","summary":"3月21日，新诺威发布2024年报，营业收入为19.81亿元，同比减少21.98%；净利润为5373万元，同比减少87.63%；扣非净利润为4234万元，同比减少94.31%。其净利润和扣非净利润，均创下2014年有公开财务数据以来新低。截至2025年一季度末，新诺威货币资金相比上年同期减少51.7%至12.99亿元。值得注意的是，根据新诺威此前发布的并购资产审计报告，2022年和2023年及2024年上半年，石药百克净利润分别为6.21亿元、7.85亿元、3.9亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071409303697a4feae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071409303697a4feae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600276","300765","01093"],"gpt_icon":0},{"id":"2548369959","title":"新诺威：截至2025年6月30日股东人数为14,066户","url":"https://stock-news.laohu8.com/highlight/detail?id=2548369959","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548369959?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:57","pubTimestamp":1751619434,"startTime":"0","endTime":"0","summary":"证券之星消息，新诺威(300765)07月04日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好，请问公司截止7月3号的股东人数是多少，谢谢新诺威回复：您好，感谢您对公司的关注，截至2025年6月30日，公司合并普通账户和融资融券信用账户股东数为14,066户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400026527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2548079174","title":"7月1日新诺威涨6.60%，工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548079174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548079174?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:29","pubTimestamp":1751358559,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日新诺威涨6.60%，收盘报55.1元，换手率1.08%，成交量13.5万手，成交额7.27亿元。重仓新诺威的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共61家，其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100026834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226","159891"],"gpt_icon":0},{"id":"2546929275","title":"新诺威：截至2025年6月20日股东总数为13,721户","url":"https://stock-news.laohu8.com/highlight/detail?id=2546929275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546929275?lang=zh_cn&edition=full","pubTime":"2025-06-25 16:54","pubTimestamp":1750841667,"startTime":"0","endTime":"0","summary":"证券之星消息，新诺威(300765)06月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2025年六月 20日公司的股东总数是多少？谢谢新诺威回复：您好，感谢您对公司的关注，截至2025年6月20日，公司合并普通账户和融资融券信用账户股东数为13,721户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062500026847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2542393090","title":"新诺威(300765.SZ)：注射用SYS6040药品临床试验申请已获得美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2542393090","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542393090?lang=zh_cn&edition=full","pubTime":"2025-06-10 15:59","pubTimestamp":1749542356,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新诺威(300765.SZ)发布公告，公司的控股子公司石药集团巨石生物制药有限公司(“巨石生物”)于近日收到美国食品药品监督管理局(以下简称“FDA”)通知，由巨石生物申报的注射用SYS6040药品临床试验申请已获得美国FDA批准，可以在美国开展临床试验。据悉，SYS6040是一款单克隆抗体偶联药物，可与肿瘤表面的特异性受体结合，通过内吞作用进入细胞并释放毒素，达到杀伤肿瘤细胞的作用。本次获批的临床适应症为晚期实体瘤。临床前研究显示，SYS6040对多种癌症显示出了较好的抗肿瘤作用，具有较高的临床开发价值。该产品已在国内外提交多项专利申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1303408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03347","BK0226","300765","BK1583","BK1576"],"gpt_icon":0},{"id":"2541808830","title":"6月6日新诺威（300765）龙虎榜数据：游资宁波桑田路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2541808830","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541808830?lang=zh_cn&edition=full","pubTime":"2025-06-06 17:14","pubTimestamp":1749201251,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年6月6日公布的交易公开信息显示，新诺威因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年6月6日收盘，新诺威报收于63.0元，上涨20.0%，涨停，换手率1.02%，成交量12.66万手，成交额7.24亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出1390.68万元，北向资金合计净卖出2308.99万元。宁波桑田路等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600026165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2541389218","title":"异动快报：新诺威（300765）6月6日14点27分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2541389218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541389218?lang=zh_cn&edition=full","pubTime":"2025-06-06 14:30","pubTimestamp":1749191458,"startTime":"0","endTime":"0","summary":"证券之星6月6日盘中消息，14点27分新诺威触及涨停板。目前价格63.0，上涨20.0%。其所属行业化学制药目前上涨。领涨股为海辰药业。该股为创新药，化学原料药，保健品概念热股，当日创新药概念上涨0.34%，化学原料药概念上涨0.25%，保健品概念上涨0.12%。6月6日的资金流向数据方面，主力资金净流入3081.75万元，占总成交额9.17%，游资资金净流入205.15万元，占总成交额0.61%，散户资金净流出3286.91万元，占总成交额9.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600016896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2539726982","title":"每周股票复盘：新诺威（300765）股东户数增加346户，户均持股减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2539726982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539726982?lang=zh_cn&edition=full","pubTime":"2025-05-31 02:26","pubTimestamp":1748629573,"startTime":"0","endTime":"0","summary":"截至2025年5月30日收盘，新诺威报收于51.91元，较上周的48.77元上涨6.44%。本周，新诺威5月30日盘中最高价报60.0元，股价触及近一年最高点。5月27日盘中最低价报47.38元。新诺威当前最新总市值729.12亿元，在化学制药板块市值排名5/150，在两市A股市值排名190/5146。本周关注点新诺威股东户数增加346户，增幅为2.9%户均持股数量从11.76万股减少至11.43万股股本股东变化近日新诺威披露，截至2025年5月20日公司股东户数为1.23万户，较5月9日增加346.0户，增幅为2.9%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053100003396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2539150232","title":"5月29日新诺威涨8.17%，工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2539150232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539150232?lang=zh_cn&edition=full","pubTime":"2025-05-29 16:33","pubTimestamp":1748507604,"startTime":"0","endTime":"0","summary":"证券之星消息，5月29日新诺威涨8.17%创60日新高，收盘报52.59元，换手率0.8%，成交量9.98万手，成交额5.15亿元。重仓新诺威的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家；过去90天内机构目标均价为46.39。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共61家，其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900024491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","300765","BK0226"],"gpt_icon":0},{"id":"2538595464","title":"新诺威(300765)5月20日股东户数1.23万户，较上期增加2.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538595464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538595464?lang=zh_cn&edition=full","pubTime":"2025-05-27 17:12","pubTimestamp":1748337178,"startTime":"0","endTime":"0","summary":"证券之星消息，近日新诺威披露，截至2025年5月20日公司股东户数为1.23万户，较5月9日增加346.0户，增幅为2.9%。在化学制药行业个股中，新诺威股东户数低于行业平均水平，截至5月20日，化学制药行业平均股东户数为3.22万户。从股价来看，2025年5月9日至2025年5月20日，新诺威区间涨幅为12.99%，在此期间股东户数增加346.0户，增幅为2.9%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052700026170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2537152443","title":"每周股票复盘：新诺威（300765）2024年年度权益分派实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2537152443","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537152443?lang=zh_cn&edition=full","pubTime":"2025-05-24 04:42","pubTimestamp":1748032931,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘，新诺威报收于48.77元，较上周的41.41元上涨17.77%。本周，新诺威5月23日盘中最高价报50.32元，股价触及近一年最高点。本周关注点公司公告汇总：新诺威2024年年度权益分派实施，每10股派发现金红利0.2元（含税）公司公告汇总新诺威发布了2024年年度权益分派实施公告。公司回购专用证券账户中的股份12,000,225股不参与本次权益分派。公司2024年年度权益分配方案已获2025年4月15日召开的2024年年度股东大会审议通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400008422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2537682918","title":"5月22日新诺威涨6.81%，工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2537682918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537682918?lang=zh_cn&edition=full","pubTime":"2025-05-22 16:32","pubTimestamp":1747902728,"startTime":"0","endTime":"0","summary":"证券之星消息，5月22日新诺威涨6.81%创60日新高，收盘报49.55元，换手率1.17%，成交量14.57万手，成交额6.99亿元。重仓新诺威的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家；过去90天内机构目标均价为46.39。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共61家，其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200024669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","300765","BK0226"],"gpt_icon":0},{"id":"2536269923","title":"5月20日新诺威涨10.33%，工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2536269923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536269923?lang=zh_cn&edition=full","pubTime":"2025-05-20 16:34","pubTimestamp":1747730069,"startTime":"0","endTime":"0","summary":"证券之星消息，5月20日新诺威涨10.33%，收盘报46.45元，换手率1.1%，成交量13.7万手，成交额6.3亿元。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共61家，其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052000025137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226","159891"],"gpt_icon":0},{"id":"2536992296","title":"新诺威涨10.33%，东吴证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2536992296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536992296?lang=zh_cn&edition=full","pubTime":"2025-05-20 16:34","pubTimestamp":1747730062,"startTime":"0","endTime":"0","summary":"今日新诺威涨10.33%，收盘报46.45元。2025年3月5日，东吴证券研究员朱国广发布了对新诺威的研报《创新加码重塑估值，双轮发展助力巨头转型》，该研报对新诺威给出“买入”评级。研报中预测公司2024-2026年收入分别为19.69亿/23.92亿/27.65亿。综合考虑公司成长潜力大，首次覆盖，给予“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为东吴证券的朱国广。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052000025133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","300765"],"gpt_icon":0},{"id":"2536943665","title":"上市公司重大资产重组新规落地，并购重组概念股连续第二日活跃，新诺威涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536943665","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536943665?lang=zh_cn&edition=full","pubTime":"2025-05-20 11:23","pubTimestamp":1747711391,"startTime":"0","endTime":"0","summary":"继昨日集体上涨后，A股市场并购重组概念股今日再度集体走强。消息面上，5月16日，中国证监会正式对外公布实施修订后的《上市公司重大资产重组管理办法》，在简化审核程序、创新交易工具、提升监管包容度等方面作出优化。业内人士指出，监管部门在鼓励上市公司并购重组方面采取了一系列措施，重组办法作为上市公司并购重组的“基本法”，优化后将在更大程度上提振市场各方信心、提升并购积极性，赋能上市公司高质量发展。","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2025/05/cms_20250520112311905.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2025/05/cms_20250520112311905.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.jrj.com.cn/2025/05/20112350524551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["161123","300765","BK0226"],"gpt_icon":0},{"id":"2536003105","title":"新诺威：截至2025年5月9日公司合并普通账户和融资融券信用账户股东数为11946户","url":"https://stock-news.laohu8.com/highlight/detail?id=2536003105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536003105?lang=zh_cn&edition=full","pubTime":"2025-05-19 17:54","pubTimestamp":1747648448,"startTime":"0","endTime":"0","summary":"证券之星消息，新诺威(300765)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问公司截止5.10最新股东户数是多少？谢谢。新诺威回复：您好，感谢您对公司的关注，截至2025年5月9日，公司合并普通账户和融资融券信用账户股东数为11,946户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051900024708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2536505645","title":"新诺威最新公告：控股子公司巨石生物SYS6010（CPO301）抗体偶联药物获得美国FDA快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2536505645","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536505645?lang=zh_cn&edition=full","pubTime":"2025-05-19 16:35","pubTimestamp":1747643724,"startTime":"0","endTime":"0","summary":"新诺威(300765.SZ)公告称，公司控股子公司巨石生物研发的SYS6010（CPO301）药物近日获得美国FDA授予的快速通道资格认定，用于治疗不伴有EGFR突变或其他驱动基因改变的且既往经含铂化疗和抗PD-(L)1治疗后疾病进展的晚期或转移性非鳞非小细胞肺癌（Nsq-NSCLC）成年患者。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051900021685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2536570659","title":"新诺威(300765.SZ)子公司SYS6010(CPO301)抗体偶联药物获得美国FDA快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2536570659","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536570659?lang=zh_cn&edition=full","pubTime":"2025-05-19 15:44","pubTimestamp":1747640688,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新诺威 发布公告，公司的控股子公司石药集团巨石生物制药有限公司所研发的SYS6010药物于近日获得美国食品药品监督管理局授予用于治疗不伴有表皮生长因子受体突变或其他驱动基因改变的，且既往经含铂化疗和抗PD-1治疗后疾病进展的晚期或转移性非鳞非小细胞肺癌成年患者的快速通道资格认定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1294747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"新诺威(300765.SZ)子公司SYS6010(CPO301)抗体偶联药物获得美国FDA快速通道资格","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300765","BK0226"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753221473609,"stockEarnings":[{"period":"1week","weight":-0.0328},{"period":"1month","weight":-0.0135},{"period":"3month","weight":0.1743},{"period":"6month","weight":0.8728},{"period":"1year","weight":1.0019},{"period":"ytd","weight":0.9764}],"compareEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0866},{"period":"6month","weight":0.1089},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0686}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"石药创新制药股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"13866人(较上一季度减少1.42%)","perCapita":"89937股","listingDate":"2019-03-22","address":"河北省石家庄市栾城区张举路62号","registeredCapital":"140459万元","survey":"　　石药创新制药股份有限公司的主营业务是大健康领域功能食品的研发、生产与销售。公司的主要产品是恩朗苏拜单抗注射液、注射用奥马珠单抗注射液、咖啡因、阿卡波糖、果维康维生素C咀嚼片。公司“果维康”商标为中国驰名商标。","listedPrice":24.47},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新诺威,300765,新诺威股票,新诺威股票老虎,新诺威股票老虎国际,新诺威行情,新诺威股票行情,新诺威股价,新诺威股市,新诺威股票价格,新诺威股票交易,新诺威股票购买,新诺威股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}